What is the treatment for skin fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Skin Fungal Infections

Topical antifungal agents are the first-line treatment for most skin fungal infections, with specific systemic therapy reserved for extensive, resistant, or specific types of infections. 1

Treatment by Type of Skin Fungal Infection

Candidal Skin Infections and Intertrigo

  • Topical azoles (clotrimazole, miconazole) and polyenes (nystatin) are effective for treating candidal skin infections, especially in skin folds of obese and diabetic patients 1
  • Keeping the infected area dry is crucial for successful treatment 1
  • For paronychia (infection around the nail), drainage is the most important intervention, followed by antifungal therapy 1

Dermatophyte Infections (Tinea)

Tinea Corporis/Cruris (Body/Groin)

  • Topical azoles or allylamines for 2-4 weeks are typically effective 2, 3
  • For widespread or resistant infections, oral therapy may be required:
    • Fluconazole 150 mg once weekly for 2-3 weeks 4
    • Itraconazole 100 mg daily for 2 weeks or 200 mg daily for 7 days 4
    • Terbinafine 250 mg daily for 1-2 weeks 4

Tinea Pedis (Athlete's Foot)

  • Topical antifungals for 4-8 weeks 2, 3
  • For extensive or resistant cases, oral therapy:
    • Fluconazole 150 mg once weekly 4
    • Itraconazole 100 mg daily for 2 weeks or 400 mg daily for 1 week 4
    • Terbinafine 250 mg daily for 2 weeks 4

Tinea Unguium (Onychomycosis)

  • Topical agents are usually ineffective for nail infections 1, 3
  • Oral therapy is required:
    • For fingernails: at least 4 months of treatment 2
    • For toenails: at least 6 months of treatment 2
    • Terbinafine or itraconazole are preferred over griseofulvin for most cases 1
    • For Candida onychomycosis specifically, azoles are preferred as terbinafine has limited activity 1

Tinea Capitis (Scalp)

  • Requires oral antifungal therapy 2, 5
  • Griseofulvin 10 mg/kg daily for 4-6 weeks is effective 2
  • For children: dosage based on weight (30-50 lbs: 125-250 mg daily; over 50 lbs: 250-500 mg daily) 2

General Principles for Treatment

  • Accurate diagnosis is essential before starting treatment - direct microscopic examination with potassium hydroxide (KOH) or culture should be performed 2, 5
  • Treatment must continue until the infecting organism is completely eradicated 2
  • Concomitant use of appropriate topical agents is often required, particularly for tinea pedis 2
  • General hygiene measures should be observed to control sources of infection or reinfection 2

Choosing Between Topical Agents

  • Azoles (miconazole, clotrimazole, ketoconazole): Fungistatic agents that are particularly effective for yeast infections like Candida 3
  • Allylamines and benzylamines (terbinafine, naftifine, butenafine): Fungicidal agents that are preferred for dermatophyte infections due to shorter treatment times and higher cure rates 3
  • For weeping infections, spray formulations may be preferred by patients 3

When to Use Systemic Therapy

Oral antifungal therapy should be considered when:

  • The infection is widespread or involves an extensive area 6, 5
  • The infection is resistant to topical therapy 2, 6
  • The infection involves hair follicles or nails 3, 5
  • For specific infections like tinea capitis that require systemic treatment 2, 5

Common Pitfalls and Caveats

  • Premature discontinuation of therapy when symptoms improve but before complete eradication of the fungus 3
  • Failure to identify and treat bacterial co-infections, especially in tinea pedis 2
  • Not keeping the infected area dry, particularly for intertrigo 1
  • Using topical therapy alone for nail infections or tinea capitis, which typically require systemic treatment 1, 3
  • Not considering non-dermatophyte causes of skin infections that may not respond to standard antifungal therapy 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical therapy for fungal infections.

American journal of clinical dermatology, 2004

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Research

Advances in topical and systemic antifungals.

Dermatologic clinics, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.